Home Cart 0 Sign in  

[ CAS No. 1181267-36-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 1181267-36-6
Chemical Structure| 1181267-36-6
Structure of 1181267-36-6 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1181267-36-6 ]

Related Doc. of [ 1181267-36-6 ]

Alternatived Products of [ 1181267-36-6 ]

Product Details of [ 1181267-36-6 ]

CAS No. :1181267-36-6 MDL No. :MFCD26960659
Formula : C21H31N3O3 Boiling Point : -
Linear Structure Formula :- InChI Key :WLBGIVZZFISEJL-UHFFFAOYSA-N
M.W : 373.49 Pubchem ID :54672427
Synonyms :

Calculated chemistry of [ 1181267-36-6 ]

Physicochemical Properties

Num. heavy atoms : 27
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.62
Num. rotatable bonds : 8
Num. H-bond acceptors : 4.0
Num. H-bond donors : 0.0
Molar Refractivity : 111.14
TPSA : 56.59 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : No
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -6.41 cm/s

Lipophilicity

Log Po/w (iLOGP) : 3.92
Log Po/w (XLOGP3) : 3.05
Log Po/w (WLOGP) : 3.81
Log Po/w (MLOGP) : 2.48
Log Po/w (SILICOS-IT) : 2.99
Consensus Log Po/w : 3.25

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.8
Solubility : 0.0598 mg/ml ; 0.00016 mol/l
Class : Soluble
Log S (Ali) : -3.9
Solubility : 0.0465 mg/ml ; 0.000125 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.76
Solubility : 0.00642 mg/ml ; 0.0000172 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 3.38

Safety of [ 1181267-36-6 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1181267-36-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1181267-36-6 ]
  • Downstream synthetic route of [ 1181267-36-6 ]

[ 1181267-36-6 ] Synthesis Path-Upstream   1~10

  • 1
  • [ 628-34-2 ]
  • [ 953071-73-3 ]
  • [ 1181267-36-6 ]
YieldReaction ConditionsOperation in experiment
92% With sodium carbonate; sodium hydroxide In water at 40℃; for 2 h; Cooling with ice To the reaction flask was added 38.00 g of 2-chloroethyl ethyl ether (compound 4, 0.35 mol) and 90.4 g of 4- (1H-benzo [d]Imidazol-2-yl) piperidine-1-carboxylate (compound 3, 0.3 mol) (40percent) in water was added 7 mlPolyethylene glycol-400,(0.25 mol NaOH and 0.1 mol Na2CO3) were added slowly under ice-cooling, and the mixture was stirred rapidly at 40C for 2 hours. After completion of the reaction, the reaction solution was cooled, extracted with ether, washed with saturated brine, dried and filtered , The solvent was removed to give 103.1 g of compound 5 in 92percent yield.
93 g With sodium iodide; sodium hydroxide In dimethyl sulfoxide at 95 - 100℃; for 3 h; Example-17: Preparation of tert-butyl 4-(l-(2-ethoxyethyl)-lH-benzo[d]imidazol-2-yl) piperidine-l-carboxylate (Formula-32) Tert-butyl 4-(lH-benzo[d]imidazol-2-yl)piperidine-l-carboxylate compound of formula-31 (100 gm), sodium iodide (10 gm) and l-chloro-2-ethoxyethane (54 gm) were slowly added to a pre-heated mixture of dimethylsulfoxide (200 ml) and sodium hydroxide (39.8 gm) at 40-45°C. Heated the reaction mixture to 95-100°C and stirred for 3 hrs at the same temperature. Cooled the reaction mixture to 10-15°C and water was slowly added. Neutralized the reaction mixture using aqueous hydrochloric acid. Ethyl acetate was added to the reaction mixture and stirred for 20 min. Both the organic and aqueous layers were separated and the organic layer was washed with sodium chloride solution. Distilled off the solvent completely from the organic layer under reduced pressure. Ethyl acetate (50 ml) was added to the obtained compound. Heated the reaction mixture to 60-65°C and stirred for 15 min at the same temperature. Reduced the temperature of the reaction mixture to 40-45°C and petroleum ether (650 ml) was slowly added. Cooled the reaction mixture to 0-5°C and stirred for 10 min at the same temperature. Filtered the precipitated solid, washed with petroleum ether and dried to get the title compound. Yield: 93.0 gm.
Reference: [1] Synthetic Communications, 2011, vol. 41, # 9, p. 1394 - 1402
[2] Patent: CN106146459, 2016, A, . Location in patent: Paragraph 0055; 0056; 0057; 0058; 0059; 0060
[3] Patent: WO2014/188453, 2014, A2, . Location in patent: Page/Page column 29
  • 2
  • [ 98139-68-5 ]
  • [ 953071-73-3 ]
  • [ 1181267-36-6 ]
YieldReaction ConditionsOperation in experiment
91% With potassium hydroxide In toluene at 50℃; Example 11 : Preparation of4-[1 -(2-ethoxyethyl)-1 H-benzoimidazol-2-yl]-piperidine-1 -carboxylic acid tert-butyl ester; In a reaction vessel, 4-(1 H-benzoimidazol-2-yl)-piperidine-1 -carboxylic acid tert-butyl ester(1.5g) prepared in the Example 10, toluene(10ml_) and potassium hydroxide(O.δg) were introduced, and temperature of the mixture was controlled to 500C or more. To the mixture, ethoxyethanol methane sulfonate^ .3g) was added, and then, it was stirred at the same temperature until the reaction was completed. After the reaction was completed, distilled water(IOmL) was added to separate layers, and then an organic layer was condensed to obtain4-[1 -(2-ethoxyethyl)-1 H-benzoimidazol-2-yl]-piperidine-1 -carboxylic acid tert-butyl ester(1.7g, 91 percent).1H-NMR, 400 MHz, CDCI3, ppm : 1.07(t, 3H)1 1.47(s, 9H), 1.92(m, 2H), 2.01 (S, 2H), 2.85(s, 2H), 3.14(m, 1 H), 3.36(m, 2H), 3.69(t, 2H), 4.28(t, 2H), 7.12-7.26(m, 3H), 7.75(t, 1 H)
91%
Stage #1: With potassium hydroxide In toluene at 50℃;
Stage #2: at 50℃;
Example 11
Preparation of 4-[1-(2-ethoxyethyl)-1H-benzoimidazol-2-yl]-piperidine-1-carboxylic acid tert-butyl ester
In a reaction vessel, 4-(1H-benzoimidazol-2-yl)-piperidine-1-carboxylic acid tert-butyl ester (1.5 g) prepared in the Example 10, toluene (10 mL) and potassium hydroxide (0.8 g) were introduced, and temperature of the mixture was controlled to 50° C. or more.
To the mixture, ethoxyethanol methane sulfonate (1.3 g) was added, and then, it was stirred at the same temperature until the reaction was completed.
After the reaction was completed, distilled water (10 mL) was added to separate layers, and then an organic layer was condensed to obtain 4-[1-(2-ethoxyethyl)-1H-benzoimidazol-2-yl]-piperidine-1-carboxylic acid tert-butyl ester (1.7 g, 91percent).
1H-NMR, 400 MHz, CDCl3, ppm: 1.07 (t, 3H), 1.47 (s, 9H), 1.92 (m, 2H), 2.01 (s, 2H), 2.85 (s, 2H), 3.14 (m, 1H), 3.36 (m, 2H), 3.69 (t, 2H), 4.28 (t, 2H), 7.12-7.26 (m, 3H), 7.75 (t, 1H)
Reference: [1] Patent: WO2009/102155, 2009, A2, . Location in patent: Page/Page column 18
[2] Patent: US2011/9636, 2011, A1, . Location in patent: Page/Page column 6
  • 3
  • [ 38385-95-4 ]
  • [ 1181267-36-6 ]
Reference: [1] Synthetic Communications, 2011, vol. 41, # 9, p. 1394 - 1402
[2] Chemical Biology and Drug Design, 2015, vol. 86, # 4, p. 509 - 516
  • 4
  • [ 95-54-5 ]
  • [ 1181267-36-6 ]
Reference: [1] Patent: WO2014/188453, 2014, A2,
[2] Chemical Biology and Drug Design, 2015, vol. 86, # 4, p. 509 - 516
  • 5
  • [ 24424-99-5 ]
  • [ 1181267-36-6 ]
Reference: [1] Synthetic Communications, 2011, vol. 41, # 9, p. 1394 - 1402
  • 6
  • [ 498-94-2 ]
  • [ 1181267-36-6 ]
Reference: [1] Chemical Biology and Drug Design, 2015, vol. 86, # 4, p. 509 - 516
  • 7
  • [ 88-74-4 ]
  • [ 1181267-36-6 ]
Reference: [1] Patent: CN106146459, 2016, A,
  • 8
  • [ 123855-51-6 ]
  • [ 1181267-36-6 ]
Reference: [1] Patent: CN106146459, 2016, A,
  • 9
  • [ 137076-22-3 ]
  • [ 1181267-36-6 ]
Reference: [1] Patent: CN106146459, 2016, A,
  • 10
  • [ 498-94-2 ]
  • [ 24424-99-5 ]
  • [ 1181267-36-6 ]
Reference: [1] Patent: WO2014/188453, 2014, A2,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 1181267-36-6 ]

Ethers

Chemical Structure| 1841081-72-8

[ 1841081-72-8 ]

1-(2-Ethoxyethyl)-2-(piperidin-4-yl)-1H-benzo[d]imidazole hydrochloride

Similarity: 0.78

Chemical Structure| 40608-76-2

[ 40608-76-2 ]

2-Benzyl-5-methoxy-1H-benzo[d]imidazole

Similarity: 0.60

Chemical Structure| 1377049-84-7

[ 1377049-84-7 ]

Methyl ((2S)-1-((2S,5S)-2-(9-(2-((2S,4S)-1-((2R)-2-((methoxycarbonyl)amino)-2-phenylacetyl)-4-(methoxymethyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-1,11-dihydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol-2-yl)-5-methylpyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate

Similarity: 0.57

Chemical Structure| 1206524-85-7

[ 1206524-85-7 ]

8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylic acid, 5-(1,1-dimethylethyl)-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-14-methoxy-3,6-dioxo-, (1ar,5s,8s,10r,22ar)-

Similarity: 0.56

Chemical Structure| 147403-65-4

[ 147403-65-4 ]

Methyl 2-ethoxy-1-((2'-(N-hydroxycarbamimidoyl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate

Similarity: 0.54

Amides

Chemical Structure| 1229000-10-5

[ 1229000-10-5 ]

tert-Butyl 3-(1H-benzo[d]imidazol-2-yl)piperidine-1-carboxylate

Similarity: 0.84

Chemical Structure| 132873-77-9

[ 132873-77-9 ]

tert-Butyl 4-(bromomethyl)-1H-benzo[d]imidazole-1-carboxylate

Similarity: 0.68

Chemical Structure| 214147-60-1

[ 214147-60-1 ]

tert-Butyl 2-chloro-1H-benzo[d]imidazole-1-carboxylate

Similarity: 0.67

Chemical Structure| 1256387-87-7

[ 1256387-87-7 ]

(1R,3S,4S)-tert-Butyl 3-(6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazol-2-yl)-2-azabicyclo[2.2.1]heptane-2-carboxylate

Similarity: 0.67

Chemical Structure| 1007882-23-6

[ 1007882-23-6 ]

Bis(2-methyl-2-propanyl) (2S,2'S)-2,2'-[4,4'-biphenyldiylbis(1H-imidazole-4,2-diyl)]di(1-pyrrolidinecarboxylate)

Similarity: 0.66

Related Parent Nucleus of
[ 1181267-36-6 ]

Piperidines

Chemical Structure| 1229000-10-5

[ 1229000-10-5 ]

tert-Butyl 3-(1H-benzo[d]imidazol-2-yl)piperidine-1-carboxylate

Similarity: 0.84

Chemical Structure| 1841081-72-8

[ 1841081-72-8 ]

1-(2-Ethoxyethyl)-2-(piperidin-4-yl)-1H-benzo[d]imidazole hydrochloride

Similarity: 0.78

Chemical Structure| 38385-95-4

[ 38385-95-4 ]

2-(Piperidin-4-yl)-1H-benzo[d]imidazole

Similarity: 0.65

Chemical Structure| 167484-91-5

[ 167484-91-5 ]

tert-Butyl 5-fluorospiro[indoline-3,4'-piperidine]-1'-carboxylate

Similarity: 0.62

Chemical Structure| 125541-22-2

[ 125541-22-2 ]

tert-Butyl 4-(phenylamino)piperidine-1-carboxylate

Similarity: 0.60

Benzimidazoles

Chemical Structure| 1229000-10-5

[ 1229000-10-5 ]

tert-Butyl 3-(1H-benzo[d]imidazol-2-yl)piperidine-1-carboxylate

Similarity: 0.84

Chemical Structure| 1841081-72-8

[ 1841081-72-8 ]

1-(2-Ethoxyethyl)-2-(piperidin-4-yl)-1H-benzo[d]imidazole hydrochloride

Similarity: 0.78

Chemical Structure| 3543-74-6

[ 3543-74-6 ]

Ethyl 4-(5-(bis(2-hydroxyethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoate

Similarity: 0.71

Chemical Structure| 3543-73-5

[ 3543-73-5 ]

Ethyl 4-(5-amino-1-methyl-1H-benzo[d]imidazol-2-yl)butanoate

Similarity: 0.69

Chemical Structure| 132873-77-9

[ 132873-77-9 ]

tert-Butyl 4-(bromomethyl)-1H-benzo[d]imidazole-1-carboxylate

Similarity: 0.68